Ország: Tajvan
Nyelv: kínai
Forrás: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Sofosbuvir;;Velpatasvir;;Voxilaprevir
香港商吉立亞醫藥有限公司台灣分公司 臺北市信義區松仁路32號10樓之1、36號10樓之1 (54376860)
J05AP56
膜衣錠
主成分 ((per tablet)) ; Sofosbuvir (0818004800) MG; Velpatasvir (0818008000) MG; Voxilaprevir (0818008100) MG
HDPE瓶裝
製 劑
須由醫師處方使用
Hovione Ltd. Hovione, Loughbeg, Ringaskiddy, Co. Cork, Ireland IE
sofosbuvir, velpatasvir and voxilaprevir
未併有肝硬化或併有代償性肝硬化(Child-Pugh A級)的成人慢性C型肝炎病毒(HCV)感染症,並且符合以下任一條件:1.基因型1、2、3、4、5或6,且曾經接受含NS5A抑制劑之HCV療程。2.基因型1a或3,且曾經接受含sofosbuvir但無NS5A抑制劑之HCV療程。
有效日期: 2025/08/31; 英文品名: Vosevi Film-Coated Tablets
2020-08-31
HCV HBV B VOSEVI BHBV HBV HCV/HBV HCV DAA HBV HCV/HBV HCV HBV HBV 5.1 1 Child-Pugh A CHCV • 12345 6 NS5A HCV • 1a 3 sofosbuvir NS5A HCV 1b 2 4 5 6 sofosbuvir NS5A HCV VOSEVI sofosbuvir/velpatasvir 2.214 2 2.1 VOSEVI HCV B HBsAg B anti-HBc HBV 5.1 2.2 VOSEVI 12.3 VOSEVI 400 sofosbuvir 100 velpatasvir 100 voxilaprevir VOSEVI 1 1Child-Pugh A HCV VOSEVI 12345 6 NS5A a 12 1a 3 Sofosbuvir NS5A b 12 a. NS5A daclatasvir elbasvir ledipasvir ombitasvir velpatasvir b. s o f o s b u v i r s o f o s b u v i r peginterferon alfa/ribavirin ribavirin HCV NS3/4A 酶 boceprevir simeprevir telaprevir 2.3 VOSEVI 8.612.3 2.4 VOSEVI Child-Pugh B C voxilaprevir 5.28.7 12.3 3 VOSEVI 400 sofosbuvir 100 velpatasvir 100 voxilaprevir GSI3 4 VOSEVI rifampin 7.312.3 5 5.1 HCV HBV B HBV HCV / HBV HCV DAA HBV B HBsAg HBV HBsAg B anti-HBc HBV HCVHBV HBV HBV HBV DNA HBV HBsAg HBV 酶 VOSEVI HCV HBsAg anti-HBc HBV HBV VOSEVI HCV HBV HBV 5.2 / HCV NS3 / 4A 酶 VOSEVI / Child-Pugh B C voxilaprevirChild-Pugh A VOSEVI / VOSEVI VOSEVIChild-Pugh B C 2.46.28.712.3 5.3 AMIODARONE amiodarone sofosbuvir amiodarone HARVONI ® ledipasvir / sofosbuvir HCV 2beta blocker / amiodarone HCV amiodarone VOSEVI amiodarone VOSEVI • • 48 2 VOSEVI amiodarone amiodarone VOSEVI amiodarone 6.2 7.3 5.4 VOSEVI P P-GP / P450 CYP P-gp / CYP2B6 CYP2C8 CYP3A4 carbamazepine sofosbuvir velpatasvir / voxilaprevir VOSEVI VOSEVI 7.3 6 • amiodarone 5.3 6.1 HCV VOSEVI POLARIS-1 POLARIS-4 445 HCV 1 2 3 4 5 6 Child- Pugh A VOSEVI 12 sofosbuvir / velpatasvir 14.114.2 VOSEVI 12 0.2% 10% 2 VOSEVI 12 5% 2 POLARIS-1 POLARIS-4 HCV VOSEVI 5% POLARIS-1 POLARIS-4 VOSEVI 12 N = 263 12 N = 152 VOSEVI 12 N = 182 SOF / VEL 12 N = 151 21% 14% 23% 23% 17% 15% 19% 23% 13% 9% 14% 3% 13% 7% 10% 3% 6% 4% 4% 6% 6% 3% 3% 1% POLARIS-1 VOSEVI 99% 1 2 POLARIS-4 VOSEVI 1 2 VOSEVI 12 5% POLARIS-1 POLARIS-4 VOSEVI < 1% < 2% POLARIS-1 1% POLARIS-4 sofosbuvir / velpatasvir POLARIS-1 POLARIS-4 VOSEVI < 1% 1% POLARIS-1 POLARIS-4 sofosbuvir / velpatasvir 1% 脂酶 Lipase 酶 3 POLARIS-1 VOSEVI 2% 3% POLARIS-4 Olvassa el a teljes dokumentumot